TELA Bio Awards Inducement Equity Grants to New Employees

TELA Bio

MALVERN, PATELA Bio, Inc. (NASDAQ: TELA) has granted restricted stock units (RSUs) covering 10,200 shares of its common stock to fourteen newly hired employees as part of their employment packages. The awards, approved by the company’s Compensation Committee on August 5, 2025, were issued under Nasdaq’s Rule 5635(c)(4) inducement grant exception.

The RSUs will vest in equal annual installments over four years, contingent on each recipient’s continued service.

TELA Bio is a commercial-stage medical technology company specializing in advanced soft-tissue reconstruction solutions designed to preserve and restore natural anatomy while minimizing reliance on permanent synthetic materials.

READ:  Palvella Therapeutics to Report Q2 Financials and Corporate Update on August 14

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.